Tools

LEADER 03334cam a2200517Ia 4500

001 ocn779347196;

003 OCoLC;

005 20141212025838.0;

008 120306s2012 dcua b 100 0 eng c;

020 a| 9780309220644;

020 a| 0309220645;

035 a| (Sirsi) o779347196;

035 a| (OCoLC)779347196;

040 a| NRZc| NRZd| YDXCPd| UtOrBLW;

049 a| NEHH;

110 2 a| National Cancer Policy Forum (U.S.)=| ^A876199;

245 14 a| Facilitating collaborations to develop combination investigational cancer therapies :b| workshop summary /c| Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.;

300 a| xiii, 103 pages :b| illustrations ;c| 23 cm;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

500 a| Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.;

504 a| Includes bibliographical references (p. 97-99).;

505 1 a| Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms.;

520 a| "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description.;

530 a| Also available online.;

650 0 a| Cancerx| Treatmentv| Congresses.=| ^A1022808;

650 0 a| Health planningz| United Statesv| Congresses.=| ^A58;

650 12 a| Neoplasmsx| drug therapy.=| ^A918295;

650 22 a| Drug Therapy, Combination.=| ^A921351;

700 1 a| Patlak, Margie.=| ^A1015055;

700 1 a| Nass, Sharyl J.=| ^A875025;

700 1 a| Balogh, Erin.=| ^A1108144;

710 2 a| National Cancer Policy Forum (U.S.)=| ^A876199;

710 2 a| Institute of Medicine (U.S.).b| Board on Health Care Services.=| ^A881507;

938 a| YBP Library Servicesb| YANKn| 7256695;

949 a| QZ 267 I59f 2012h| HSL70i| 31740008154563o| hercp| $38.00;

994 a| C0b| NEH;

096 a| QZ 267 I59f 2012;

590 a| Laupus-WCP;

596 a| 4;

998 a| 3062120;

999 a| QZ 267 I59F 2012w| NLMc| 1i| 31740008154563d| 2/22/2013e| 5/25/2012l| HSLBKm| HSLp| $38.00q| 1r| Ys| Yt| HBKu| 5/25/2012x| BOOKz| HSTACKSo| .STAFF. herc;

Facilitating collaborations to develop combination investigational cancer therapies : workshop summary / Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

Author/creator	National Cancer Policy Forum (U.S.)
Format	Book
Publication Info	Washington, D.C. : National Academies Press, ©2012.
Description	xiii, 103 pages : illustrations ; 23 cm
Subjects	Cancer--Research. --United States. --Congresses. Cancer--Treatment. --Congresses. Cancer--United States. --Prevention. --Congresses. Health planning--United States. --Congresses. Neoplasms--drug therapy. Drug Therapy, Combination.

Other author/creator	Patlak, Margie.
Other author/creator	Nass, Sharyl J.
Other author/creator	Balogh, Erin.
Other author/creator	National Cancer Policy Forum (U.S.)
Other author/creator	Institute of Medicine (U.S.). Board on Health Care Services.
Incomplete content	Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms.
Abstract	"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description.
Local note	Laupus-WCP
General note	Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.
Bibliography note	Includes bibliographical references (p. 97-99).
Other forms	Also available online.
ISBN	9780309220644
ISBN	0309220645

Availability

Library	Location	Call Number	Status	Item Actions
Laupus	Books - Stacks	QZ 267 I59F 2012	✔ Available	Place Hold

Facilitating collaborations to develop combination investigational cancer therapies : workshop summary / Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

Click here for more information about this title

Availability